All In MedTech

Company

Integra

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Integra, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Integra.

Latest FDA decisions

The 8 newest of 47 since 2015.

Search the Clearance Tracker

44 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07805798 · 300 participants (planned) · Start Aug 31, 2026 · Primary completion Aug 31, 2029

    Device: Urinary Bladder Matrix (UBM) Products · For: Tissue Repair; Soft Tissue Reconstruction; Wound Management and 8 more

  • NCT06453187 · 350 participants (planned) · Start Nov 18, 2024 · Primary completion Dec 31, 2026

    Device: Urinary Bladder Matrix (UBM) sheet device for Venous Leg Ulcers; Urinary Bladder Matrix (UBM) sheet device for Diabetic Foot Ulcers and 2 more · For: Diabetic Foot Ulcer; Venous Leg Ulcer

    Sites: Los Angeles, California; San Francisco, California; Vista, California · 13 sites in all

  • NCT06629506 · 25 participants · Start Dec 12, 2024 · Primary completion Aug 31, 2025

    Device: MicroMatrix® Flex; MicroMatrix® UBM Particulate and 1 more · For: Pressure Injury; Venous Ulcer; Necrotizing Soft Tissue Infection and 2 more

    Sites: Aurora, Colorado; Washington D.C., District of Columbia; Lake Success, New York

67 more trials with a free account

Reports received

857

Received Nov 1, 2025 to Nov 19, 2026. Includes 35 of another or unstated type.

Malfunction reports

442

52% of reports

Injury reports

377

44% of reports

Death reports

3

0.4% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 23375022
Jan 24713900
Feb 24575400
Mar 24465700
Apr 24544700
May 24545800
Jun 24714300
Jul 24504110
Aug 24645700
Sep 24474720
Oct 24405600
Nov 24623600
Dec 24523800
Jan 25583700
Feb 25584120
Mar 25563610
Apr 25484120
May 25675200
Jun 25356600
Jul 25725700
Aug 25394400
Sep 25592200
Oct 25534800
Nov 25372000
Dec 25392820
Jan 26253300
Feb 26435000
Mar 26503610
Apr 26292800
May 26533800
Jun 26253300
Jul 26352709
Aug 263336014
Sep 26322906
Oct 26411906
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

427 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.